Get notified when SNSE files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsSensei Biotherapeutics delays board appointment, sets five-director board size
Filed May 22, 2026 · Period ending May 22, 2026 · ~1 min read
Key Changes
-
low
Dr. Karen Vousden's board appointment postponed to Q3 or Q4 2026 due to personal reasons, delaying previously announced board reconstitution timeline.
Item 5.02 view on EDGAR → -
low
Board approved five-director size effective June 12, 2026, contingent on stockholder approval at June 10 Annual Meeting.
Item 5.02 view on EDGAR → -
low
Bob Holmen to chair Nominating and Corporate Governance Committee starting June 12, 2026, if stockholders approve required matters at Annual Meeting.
Item 5.02 view on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade SNSE commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 24, 2026 · How we verify